John C.M. Farquhar Sells 22,562 Shares of Heartflow (NASDAQ:HTFL) Stock

Posted by Geri Gentry on Jul 15th, 2026

Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) CEO John C.M. Farquhar sold 22,562 shares of the business’s stock in a transaction dated Friday, July 10th. The shares were sold at an average price of $27.75, for a total transaction of $626,095.50. Following the completion of the sale, the chief executive officer owned 435,373 shares in the company, valued at approximately $12,081,600.75. This trade represents a 4.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

On Wednesday, June 24th, John C.M. Farquhar sold 38,900 shares of Heartflow stock. The shares were sold at an average price of $35.00, for a total transaction of $1,361,500.00.
On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.50, for a total transaction of $643,017.00.
On Monday, May 11th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $29.12, for a total transaction of $657,005.44.

Heartflow Stock Performance

NASDAQ:HTFL opened at $25.49 on Wednesday. Heartflow, Inc. has a fifty-two week low of $20.13 and a fifty-two week high of $41.22. The company has a 50 day moving average price of $30.03 and a 200 day moving average price of $28.59. The stock has a market capitalization of $2.20 billion and a P/E ratio of -8.20.

Heartflow (NASDAQ:HTFL – Get Free Report) last announced its earnings results on Thursday, May 14th. The company reported ($0.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.08. The firm had revenue of $52.59 million during the quarter. The business’s revenue for the quarter was up 41.3% on a year-over-year basis. Research analysts forecast that Heartflow, Inc. will post -0.82 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Heartflow

Hedge funds have recently bought and sold shares of the stock. Fred Alger Management LLC purchased a new position in Heartflow in the third quarter valued at $9,997,000. JPMorgan Chase & Co. purchased a new stake in Heartflow during the 3rd quarter worth about $13,887,000. Bamco Inc. NY acquired a new position in shares of Heartflow during the 3rd quarter worth about $41,654,000. UBS Group AG increased its holdings in shares of Heartflow by 228.8% in the 4th quarter. UBS Group AG now owns 501,165 shares of the company’s stock valued at $14,609,000 after acquiring an additional 348,753 shares during the last quarter. Finally, Seven Grand Managers LLC raised its position in shares of Heartflow by 100.0% during the 4th quarter. Seven Grand Managers LLC now owns 100,000 shares of the company’s stock worth $2,915,000 after acquiring an additional 50,000 shares in the last quarter.

Wall Street Analyst Weigh In

HTFL has been the topic of several research reports. Wells Fargo & Company increased their target price on Heartflow from $35.00 to $37.00 and gave the stock an “overweight” rating in a research note on Friday, May 15th. Piper Sandler reissued an “overweight” rating on shares of Heartflow in a research report on Thursday, June 11th. JPMorgan Chase & Co. lowered their price objective on shares of Heartflow from $40.00 to $35.00 and set an “overweight” rating for the company in a research note on Thursday, March 19th. Canaccord Genuity Group dropped their price objective on shares of Heartflow from $43.00 to $37.00 and set a “buy” rating for the company in a report on Friday, May 15th. Finally, Weiss Ratings lowered shares of Heartflow from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, July 8th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $37.00.

View Our Latest Analysis on Heartflow

Heartflow Company Profile

(Get Free Report)

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.